Journal News

Unlocking how cellular proteins control cancer spread

New finding may help focus the search for anti-cancer drugs
Erin Matthews
By Erin Matthews
August 29, 2020

A new insight into cell signals that control cancer growth and migration could help in the search for effective anti-cancer drugs. A McGill University-led study reveals key biochemical processes that advance our understanding of colorectal cancer, the third most common cancer among Canadians.

Using the Canadian Macromolecular Crystallography Facility beamline at the Canadian Light Source at the University of Saskatchewan, scientists from McGill University and Osaka University in Japan were able to unlock the behavior of an enzyme involved in the spread of cancer cells. In a study published in the Journal of Biological Chemistry, the team found that there is a delicate interaction between the enzyme, PRL3, and another protein that moves magnesium in and out of cells. This interaction is crucial to colorectal cancer growth.

JBC-McGill-paper-700x506.jpg
Kalle Gehring et al./JBC
Immunofluorescence images of HEK293 cells showing proper localization of transfected PRL3 mutants except C104N.

"These enzymes were first seen in liver cells that were activated to start growing, so somehow they act as a growth signal," said McGill biochemistry professor and corresponding author Kalle Gehring.

It was generally believed that PRL3 proteins acted as enzymes to control cancer cells. Therefore, it came as a surprise when Gehring and his team found that a mutation that leads to a loss of the enzyme activity still maintained the same influence over cancer growth and migration. "What our new paper showed is that a second activity of PRL3, control of a magnesium transporter, is the signal that instructs the cancer to travel to other parts of the body. It was very exciting that the mutant protein that has no catalytic activity, but still binds very tightly to magnesium transport proteins, turned out to be as oncogenic as the wild-type protein," said Gehring.

The team's findings call into question long-standing hypotheses about the role PRL3 plays in the spread of cancer and indicate that the binding mechanism is somehow key.

Understanding that binding the magnesium transporters and not the enzyme's catalytic activity influences cancer growth and migration signaling is key information for identifying novel compounds to prevent cancer spread. Current drug screening against PRL3 has focused on identifying compounds that block phosphatase activity. By testing the wrong function, the screens may have missed other compounds of therapeutic interest. Shifting the focus to the enzyme's ability to bind to magnesium transporters is one way to help companies identify better therapeutics for cancer through drug screening methods.

Future work will include more detailed studies on the role of the magnesium transporter and its interactions with PRL3.

 

Erin Matthews
Erin Matthews

Erin Matthews is a freelance science writer with a focus on health, biology and biotechnology. She has been the summer communications assistant at the Canadian Light Source for the last two seasons.

Join the ASBMB Today mailing list

Sign up to get updates on articles, interviews and events.

Latest in Science

Science highlights or most popular articles

Rodents in space Keeping bone and muscle strong on the ISS
News

Rodents in space Keeping bone and muscle strong on the ISS

September 19, 2020

Researchers helped mice stay mighty with an experiment to counter the effects of microgravity. The gene treatment might also enhance muscle and bone health on Earth — and in humans.

Understanding the impact of Type 1 diabetes susceptibility genes
Research Spotlight

Understanding the impact of Type 1 diabetes susceptibility genes

September 17, 2020

Starting in eighth grade, a series of mentors who saw something special in Sharifa Love–Rutledge helped her stay on the path to being a researcher — and becoming a mentor to others.

Re-creating coagulation in a lab
Journal News

Re-creating coagulation in a lab

September 15, 2020

Threatened arthropods are in the crossfire of medical and conservation efforts, but new research could benefit horseshoe crabs and humans alike.

Decoy receptor neutralizes coronavirus in cell cultures
News

Decoy receptor neutralizes coronavirus in cell cultures

September 13, 2020

To keep COVID-19 from infecting tissues once they’re exposed, a new study led by Erik Procko suggests luring the virus with an engineered, free-floating receptor protein that binds the virus and blocks infection.

When plants and their microbes are not in sync, the results can be disastrous
News

When plants and their microbes are not in sync, the results can be disastrous

September 06, 2020

Sheng-Yang He’s lab has discovered that plants can develop dysbiosis, a condition similar to inflammatory bowel disease in humans, with severe consequences.

A zest for synthetic biology
Feature

A zest for synthetic biology

September 02, 2020

Metabolic engineers seek to overcome the challenges of mass-producing commodity chemicals, such as limonene, an oil from orange peels.